rs1800839

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The ENST00000557356.5(PSEN1):​c.-161C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.056 in 152,976 control chromosomes in the GnomAD database, including 324 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.056 ( 324 hom., cov: 33)
Exomes 𝑓: 0.054 ( 0 hom. )

Consequence

PSEN1
ENST00000557356.5 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.71

Publications

9 publications found
Variant links:
Genes affected
PSEN1 (HGNC:9508): (presenilin 1) Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1; PSEN2) or in the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor, such that they either directly regulate gamma-secretase activity or themselves are protease enzymes. Several alternatively spliced transcript variants encoding different isoforms have been identified for this gene, the full-length nature of only some have been determined. [provided by RefSeq, Aug 2008]
PSEN1 Gene-Disease associations (from GenCC):
  • Alzheimer disease 3
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Pick disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • semantic dementia
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • behavioral variant of frontotemporal dementia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset autosomal dominant Alzheimer disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • acne inversa, familial, 3
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy 1U
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 14-73136423-C-T is Benign according to our data. Variant chr14-73136423-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 369076.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0867 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSEN1NM_000021.4 linkc.-296C>T upstream_gene_variant ENST00000324501.10 NP_000012.1 P49768-1A0A024R6A3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSEN1ENST00000324501.10 linkc.-296C>T upstream_gene_variant 1 NM_000021.4 ENSP00000326366.5 P49768-1

Frequencies

GnomAD3 genomes
AF:
0.0561
AC:
8534
AN:
152196
Hom.:
324
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0162
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.0416
Gnomad ASJ
AF:
0.0620
Gnomad EAS
AF:
0.00867
Gnomad SAS
AF:
0.0163
Gnomad FIN
AF:
0.0688
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0886
Gnomad OTH
AF:
0.0522
GnomAD4 exome
AF:
0.0544
AC:
36
AN:
662
Hom.:
0
Cov.:
0
AF XY:
0.0482
AC XY:
21
AN XY:
436
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
4
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
1
AN:
4
East Asian (EAS)
AF:
0.00
AC:
0
AN:
8
South Asian (SAS)
AF:
0.00
AC:
0
AN:
8
European-Finnish (FIN)
AF:
0.0461
AC:
20
AN:
434
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.0722
AC:
14
AN:
194
Other (OTH)
AF:
0.125
AC:
1
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0560
AC:
8533
AN:
152314
Hom.:
324
Cov.:
33
AF XY:
0.0533
AC XY:
3968
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0162
AC:
672
AN:
41586
American (AMR)
AF:
0.0415
AC:
635
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0620
AC:
215
AN:
3468
East Asian (EAS)
AF:
0.00869
AC:
45
AN:
5180
South Asian (SAS)
AF:
0.0166
AC:
80
AN:
4830
European-Finnish (FIN)
AF:
0.0688
AC:
730
AN:
10606
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0886
AC:
6025
AN:
68022
Other (OTH)
AF:
0.0517
AC:
109
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
443
886
1328
1771
2214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0627
Hom.:
177
Bravo
AF:
0.0532
Asia WGS
AF:
0.0160
AC:
57
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dilated Cardiomyopathy, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pick disease;C0338451:Frontotemporal dementia;C1843013:Alzheimer disease 3;C3151038:Acne inversa, familial, 3 Benign:1
Oct 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Early-onset autosomal dominant Alzheimer disease Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
16
DANN
Benign
0.81
PhyloP100
1.7
PromoterAI
-0.27
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800839; hg19: chr14-73603131; API